| Advances and challenges of liposome assisted drug delivery L Sercombe, T Veerati, F Moheimani, SY Wu, AK Sood, S Hua Frontiers in pharmacology 6, 286, 2015 | 1970 | 2015 |
| Current trends and challenges in the clinical translation of nanoparticulate nanomedicines: pathways for translational development and commercialization S Hua, MBC De Matos, JM Metselaar, G Storm Frontiers in pharmacology 9, 790, 2018 | 603 | 2018 |
| Advances in oral nano-delivery systems for colon targeted drug delivery in inflammatory bowel disease: selective targeting to diseased versus healthy tissue S Hua, E Marks, JJ Schneider, S Keely Nanomedicine: nanotechnology, biology and medicine 11 (5), 1117-1132, 2015 | 443 | 2015 |
| Lipid-based nano-delivery systems for skin delivery of drugs and bioactives S Hua Frontiers in pharmacology 6, 219, 2015 | 241 | 2015 |
| Advances in oral drug delivery for regional targeting in the gastrointestinal tract-influence of physiological, pathophysiological and pharmaceutical factors S Hua Frontiers in pharmacology 11, 524, 2020 | 204 | 2020 |
| The use of lipid-based nanocarriers for targeted pain therapies S Hua, SY Wu Frontiers in pharmacology 4, 143, 2013 | 193 | 2013 |
| Advantages and limitations of current imaging techniques for characterizing liposome morphology AL Robson, PC Dastoor, J Flynn, W Palmer, A Martin, DW Smith, A Woldu, ... Frontiers in pharmacology 9, 80, 2018 | 135 | 2018 |
| Targeting sites of inflammation: intercellular adhesion molecule-1 as a target for novel inflammatory therapies S Hua Frontiers in pharmacology 4, 127, 2013 | 109 | 2013 |
| A role for acute-phase serum amyloid A and high-density lipoprotein in oxidative stress, endothelial dysfunction and atherosclerosis S Hua, C Song, CL Geczy, SB Freedman, PK Witting Redox Report 14 (5), 187-196, 2009 | 109 | 2009 |
| Targeting peripheral opioid receptors to promote analgesic and anti-inflammatory actions KS Iwaszkiewicz, JJ Schneider, S Hua Frontiers in pharmacology 4, 132, 2013 | 107 | 2013 |
| Advances in nanoparticulate drug delivery approaches for sublingual and buccal administration S Hua Frontiers in pharmacology 10, 1328, 2019 | 105 | 2019 |
| Physiological and pharmaceutical considerations for rectal drug formulations S Hua Frontiers in pharmacology 10, 1196, 2019 | 105 | 2019 |
| Mechanisms of peripheral immune-cell-mediated analgesia in inflammation: clinical and therapeutic implications S Hua, PJ Cabot Trends in Pharmacological Sciences 31 (9), 427-433, 2010 | 101 | 2010 |
| Advantages and limitations of current techniques for analyzing the biodistribution of nanoparticles L Arms, DW Smith, J Flynn, W Palmer, A Martin, A Woldu, S Hua Frontiers in Pharmacology 9, 802, 2018 | 94 | 2018 |
| Hypoxia-inducible factor (HIF) as a target for novel therapies in rheumatoid arthritis S Hua, TH Dias Frontiers in pharmacology 7, 184, 2016 | 89 | 2016 |
| Comparison of in vitro dialysis release methods of loperamide-encapsulated liposomal gel for topical drug delivery S Hua International journal of nanomedicine, 735-744, 2014 | 87 | 2014 |
| Extracellular matrix-mediated regulation of cancer stem cells and chemoresistance Y Brown, S Hua, PS Tanwar The international journal of biochemistry & cell biology 109, 90-104, 2019 | 75 | 2019 |
| Drug delivery to the human and mouse uterus using immunoliposomes targeted to the oxytocin receptor JW Paul, S Hua, M Ilicic, JM Tolosa, T Butler, S Robertson, R Smith American journal of obstetrics and gynecology 216 (3), 283. e1-283. e14, 2017 | 75 | 2017 |
| Targeted nanoparticles that mimic immune cells in pain control inducing analgesic and anti-inflammatory actions: a potential novel treatment of acute and chronic pain condition S Hua, PJ Cabot Pain physician 16 (3), E199, 2013 | 67 | 2013 |
| The acute-phase protein serum amyloid A induces endothelial dysfunction that is inhibited by high-density lipoprotein PK Witting, C Song, K Hsu, S Hua, SN Parry, R Aran, C Geczy, ... Free Radical Biology and Medicine 51 (7), 1390-1398, 2011 | 66 | 2011 |
